Dandekar Atul Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
2
Insider Sells Sum
$2.94M

Insider Activity of Dandekar Atul

According to the SEC Form 4 filings, Dandekar Atul, being in a position of

  1. CSBO at Maze Therapeutics, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 146434 shares for $5.11M,
    over all time since 2025-12-29, has bought 0 shares, and sold 146434 shares for $5.11M.

Biography of Dandekar Atul

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $000
Sells
 $5,114,93013100

Comparison of Insiders on Amount of Buys and Sells

2026-10-29SaleMaze Therapeutics, Inc.
MAZE
CSBO
7,500
0.0136%
$32.07$240,532-1.41%
2026-09-29SaleMaze Therapeutics, Inc.
MAZE
CSBO
7,500
0.0136%
$27.06$202,921+2.52%
2026-09-03SaleMaze Therapeutics, Inc.
MAZE
CSBO
3,243
0.0059%
$26.01$84,354+3.42%
2026-09-02SaleMaze Therapeutics, Inc.
MAZE
CSBO
3,191
0.0057%
$26.47$84,457-0.22%
2026-08-28SaleMaze Therapeutics, Inc.
MAZE
CSBO
7,500
0.0128%
$27.58$206,824-2.86%
2026-07-29SaleMaze Therapeutics, Inc.
MAZE
CSBO
7,500
0.0136%
$27.34$205,031+0.42%
2026-06-29SaleMaze Therapeutics, Inc.
MAZE
CSBO
7,500
0.0131%
$28.02$210,150-4.52%
2026-05-29SaleMaze Therapeutics, Inc.
MAZE
CSBO
7,500
0.0135%
$26.34$197,554+3.7%
2026-04-29SaleMaze Therapeutics, Inc.
MAZE
CSBO
7,500
0.0134%
$25.37$190,299+5.22%
2026-03-30SaleMaze Therapeutics, Inc.
MAZE
CSBO
7,500
0.0154%
$29.34$220,019-6.86%
2026-01-29SaleMaze Therapeutics, Inc.
MAZE
CSBO
7,500
0.0153%
$44.27$331,990-38.48%
2025-12-30SaleMaze Therapeutics, Inc.
MAZE
CSBO
100
0.0002%
$40.36$4,036-29.53%
2025-12-29SaleMaze Therapeutics, Inc.
MAZE
CSBO
72,400
0.155%
$40.56$2.94M-30.14%
Total: 13
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.